Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

152,299 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Furazolidone-containing triple and quadruple eradication therapy for initial treatment for Helicobacter pylori infection: A multicenter randomized controlled trial in China.
Xie Y, Zhang Z, Hong J, Liu W, Lu H, Du Y, Wang W, Xu J, Wang X, Huo L, Zhang G, Lan C, Li X, Li Y, Wang H, Zhang G, Zhu Y, Shu X, Chen Y, Wang J, Lu N; Chinese Society of Gastroenterology Chinese Study Group on Helicobacter pylori. Xie Y, et al. Among authors: wang x, wang h, wang w, wang j. Helicobacter. 2018 Oct;23(5):e12496. doi: 10.1111/hel.12496. Epub 2018 Jul 22. Helicobacter. 2018. PMID: 30033619 Clinical Trial.
[Detection of Serum Peptides in Patients with Lung Squamous Cell Carcinoma by MALDI-TOF-MS and Analysis of Their Correlation with Chemotherapy Efficacy].
Zhao G, Xu B, Li X, Tang C, Qin H, Wang H, Yang S, Wang W, Gao H, He K, Liu X. Zhao G, et al. Among authors: wang h, wang w. Zhongguo Fei Ai Za Zhi. 2017 May 20;20(5):318-325. doi: 10.3779/j.issn.1009-3419.2017.05.04. Zhongguo Fei Ai Za Zhi. 2017. PMID: 28532539 Free PMC article. Clinical Trial. Chinese.
Circulating plasma microRNAs as potential markers to identify EGFR mutation status and to monitor epidermal growth factor receptor-tyrosine kinase inhibitor treatment in patients with advanced non-small cell lung cancer.
Qu L, Li L, Zheng X, Fu H, Tang C, Qin H, Li X, Wang H, Li J, Wang W, Yang S, Wang L, Zhao G, Lv P, Lei Y, Zhang M, Gao H, Song S, Liu X. Qu L, et al. Among authors: wang h, wang w, wang l. Oncotarget. 2017 Jul 11;8(28):45807-45824. doi: 10.18632/oncotarget.17416. Oncotarget. 2017. PMID: 28496005 Free PMC article.
Genomic alterations and clinical outcomes in patients with lung adenocarcinoma with transformation to small cell lung cancer after treatment with EGFR tyrosine kinase inhibitors: A multicenter retrospective study.
Wang W, Xu C, Chen H, Jia J, Wang L, Feng H, Wang H, Song Z, Yang N, Zhang Y. Wang W, et al. Among authors: wang h, wang l. Lung Cancer. 2021 May;155:20-27. doi: 10.1016/j.lungcan.2021.03.006. Epub 2021 Mar 9. Lung Cancer. 2021. PMID: 33714778
152,299 results
You have reached the last available page of results. Please see the User Guide for more information.